Qube Research & Technologies (QRT)’s ProShares Trust Short MSCI EAFE EFZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251 Sell
10
-50
-83% -$1.22K ﹤0.01% 3463
2025
Q4
$1.52K Hold
60
﹤0.01% 3592
2025
Q3
$1.6K Hold
60
﹤0.01% 3483
2025
Q2
$1.65K Hold
60
﹤0.01% 3470
2025
Q1
$1.86K Hold
60
﹤0.01% 3405
2024
Q4
$2K Hold
60
﹤0.01% 3375
2024
Q3
$1.83K Hold
60
﹤0.01% 3177
2024
Q2
$1.97K Hold
60
﹤0.01% 3185
2024
Q1
$1.96K Hold
60
﹤0.01% 3997
2023
Q4
$2.06K Hold
60
﹤0.01% 3817
2023
Q3
$2.28K Sell
60
-894
-94% -$32.7K ﹤0.01% 3557
2023
Q2
$65.6K Buy
954
+894
+1,490% +$32.5K ﹤0.01% 2027
2023
Q1
$2.21K Buy
+60
New +$2.26K ﹤0.01% 2447

Other funds holding EFZ

Qube Research & Technologies (QRT)'s EFZ Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its ProShares Trust Short MSCI EAFE (EFZ) stake by 83% in Q1 2026, selling an estimated $1.22K and leaving 10 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

Qube Research & Technologies (QRT) first reported a position in EFZ in Q1 2023 and has held it in 13 quarters since. The position peaked at $65.6K in Q2 2023. 13 funds tracked by Wall St. Rank hold EFZ as of Q1 2026.

  • Qube Research & Technologies (QRT) held 10 shares of ProShares Trust Short MSCI EAFE worth $251 as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 50 ProShares Trust Short MSCI EAFE shares in Q1 2026, an estimated $1.22K.
  • ProShares Trust Short MSCI EAFE made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3463 holding.
  • Qube Research & Technologies (QRT) first reported a position in ProShares Trust Short MSCI EAFE in Q1 2023 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s ProShares Trust Short MSCI EAFE position peaked at $65.6K in Q2 2023.
  • 13 funds tracked by Wall St. Rank held ProShares Trust Short MSCI EAFE as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.